Ovarian cancer: Widower warns of 'sneaky' symptoms
A widower has said his wife received a late and terminal diagnosis due to an ongoing lack of awareness about symptoms of ovarian cancer among health professionals.Stephen McCormick, whose wife Julie was diagnosed with stage 3 ovarian cancer, said the disease shouldn't be ruled out as symptoms can be associated with other less serious conditions.About 200 women are diagnosed with ovarian cancer in Northern Ireland each year. The Department of Health and the Public Health Agency both said that due to constraints on the health budget there has been a "freeze" on almost all advertising spend across Health and Social Care.
"I think doctors need to rule it in before they rule it out, particularly if symptoms persist when a woman is being investigated for gynaecological or stomach problems," the County Down man said.Julie first complained of pelvic pain in 2021, however, it took a further two and a half years of investigations and tests before ovarian cancer was diagnosed. Julie died 12 months later, aged 65.Mr McCormick said his wife, an oncology nurse, was "fooled" by early tests being negative despite prolonged symptoms telling her something wasn't right.A CA125 blood test, which is used to measure a level of protein in the blood and is not a definitive test for ovarian cancer was initially clear and caused no concern.But according to Mr McCormick, despite his wife's constant visits to the GP and other specialists with stomach pain and gynae issues, ovarian cancer wasn't a line of inquiry.
'On a mission'
Mr McCormick said he's "passionate" about raising awareness of ovarian cancer and is "on a mission" to get a public awareness campaign up and running across Northern Ireland.That mission began on 23 June 2024, the day Julie died.
Posting on social media that day, Mr McCormick urged the public to be aware of the "sneaky symptoms" of ovarian cancer and to get checked if they persist. One year on, he said little has changed with no desire among politicians and health officials to put it on the Executive's agenda."I'd like a big billboard, radio and television campaign educating people about the symptoms and that if they persist you should continue seeking help and suggesting being tested for ovarian cancer," said Mr McCormick. "When you are diagnosed late, the outcomes are much poorer and therefore if women can get to see their GP sooner, they have a better chance of being diagnosed and a better chance of survival."He also said he isn't confident that the Department of Health will decide to go big on the cancer as he appreciates it has a long list of priorities.
Research by Queen's University Belfast has found the most common route for women to be diagnosed with ovarian cancer was in an Emergency Department.Between 2017 and 2021, 35% (70) of cases were diagnosed on average each year via an emergency presentation, and 27% (55) of cases were diagnosed by a red-flag referral route.Dr Damien Bennett, director of the NI Cancer Registry, said the findings highlighted the need to drive home the message that if symptoms persist - including if they happen 12 times in a month - it is not something that should be ignored and should be immediately followed up with the woman's GP."These symptoms can overlap with other conditions that are benign and can potentially make it more difficult for the public to potentially approach health care professionals," he said. "Those symptoms also make it more difficult for health care professionals to come to a diagnosis - but the greater awareness about all of this the better."The research also found that 32% of cases were diagnosed at stage 1 (early stage), while 20% were diagnosed at an advanced stage.On average there were 122 deaths per year from ovarian cancer.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
2 hours ago
- The Independent
Officials warn pet owners about toxic chemicals found in fake medicines
Officials have issued an urgent warning to pet owners after toxic insecticides traces were found in a fake flea treatment. The Intellectual Property Office (IPO) and Veterinary Medicine Directorate (VMD) said pet owners should take caution when purchasing common medicines to ensure they are not counterfeit. It comes after a fake flea treatment caused Alan Wall's pet cat Smokey to fall seriously ill. Mr Wall, from Preston, had bought what appeared to be genuine Frontline flea treatment online for Smokey. The cat required emergency intestinal surgery followed by a week-long stay at the veterinary clinic, which led to significant bills. Mr Wall said: 'Smokey is more than just a pet, he's a member of our family. 'When he became ill after using what we believed was a genuine flea treatment, we were terrified. 'Watching him suffer, not knowing whether he would pull through, was heartbreaking. It's taken a huge emotional toll on all of us.' Mr Wall later had the product tested in a laboratory by experts at the University of Bath, who confirmed the presence of Pirimiphos-methyl, a dangerous insecticide toxic to cats. The VMD and IPO have now alerted pet owners to be vigilant to the signs of counterfeit products, which are illegal to sell in the UK. Those seeking bargains or a quick purchase online may unknowingly buy fake medicines or treatments. The counterfeits deliberately copy the appearance, packaging and branding of genuine veterinary products but lack proper active ingredients. This means they are ineffective or even harmful to pets, causing severe reactions including vomiting, muscle tremors, breathing difficulties, seizures and potentially death. Officials say owners should check for warning signs including poor packaging, spelling errors, missing information and unusual smells. Last year alone, the VMD issued 122 seizure notices for the selling of unauthorised animal medicines and supplements, preventing around 18,000 illegal items from reaching consumers. Mr Wall said: 'Without the support of our vets and the extensive surgery they performed we know Smokey wouldn't be with us today. 'We want to warn other pet owners about these fake products so that no one else has to endure what we've been through.' Sue Horseman from Bristol also purchased what appeared to be Frontline flea treatment online for her cat, but quickly became suspicious that the product was not genuine because it was difficult to open and smelt of white spirit and paraffin. While the online platform has removed the seller, they had already managed to sell 211 batches of suspected counterfeit pet medicines and supplements, including fake Frontline Flea and Tick Treatment and Pro Plan FortiFlora Probiotic Sachets for dogs and cats. New IPO research shows that counterfeit goods of all types are frequently purchased via global e-commerce websites. The figures also suggest that in 2024, nearly one in five (17%) consumers unknowingly purchased goods later found to be fake, with 60% of purchasers also saying that 'ease of purchasing' influenced their decision and 72% saying price was an important factor in their decision. Helen Barnham, the IPO's deputy director of enforcement, said: 'Counterfeiting is anything but a victimless crime and this latest discovery confirms this. 'If you suspect that any goods offered for sale may be counterfeit, you should always report this to your local Trading Standards or Crimestoppers Online.' Caroline Allen, RSPCA chief veterinary officer, said: 'We are very concerned about counterfeit vet treatments on sale which can be highly toxic to pets and we would always urge pet owners to seek professional veterinary advice if they have any health concerns. 'We appreciate financial pressures can lead to some owners to look for cheaper treatments online but they could be unwittingly putting their beloved pets in serious danger by inadvertently buying these counterfeit goods and would urge them to take on board this Government advice.'
Sky News
3 hours ago
- Sky News
Working-class communities, rural areas and coastal towns to receive extra NHS funding
NHS funding will be diverted to working-class communities, the health secretary is set to announce. Wes Streeting is expected to announce the measure as part of the upcoming NHS 10-year plan, set to be focused on closing health inequalities, during a speech in Blackpool today. About £2.2bn will be spent on staff, medicines, new technology and equipment in rural communities, coastal towns and working-class regions, according to the Department of Health. 3:09 The money, which was previously set aside to plug financial holes in the health service, can now be reinvested where it is "most needed", the department said. It added that NHS leaders have spent months cutting "wasteful" spending, such as on "back office" functions and agency staff, while reducing forecast deficits by health trusts. GP funding will be reviewed under the new plan, as surgeries serving working-class areas receive an average of 10% less funding per patient than practices in more affluent areas. Practices in some of England's poorest areas have about 300 more patients per GP than the most affluent areas, data by the Royal College of GPs suggests. 5:52 The Department of Health said poorer communities had been "neglected" for years and often have the fewest GPs, the worst performing services and the longest waits. Mr Streeting is expected to say during the announcement of the plan that "those in greatest need often receive the worst quality healthcare". He will say that this "flies in the face of the values the NHS was founded on" as "the circumstances of your birth shouldn't determine your worth". Mr Streeting is set to add: "A core ambition of our 10-year plan will be to restore the promise of the NHS, to provide first-class healthcare for everyone in our country and end the postcode lottery." The government "will prioritise investment" where towns have the greatest health needs and the fewest GPs, according to Mr Streeting.
Daily Mail
4 hours ago
- Daily Mail
World's most deadly diseases will be kept at new Surrey lab
The world's most dangerous diseases will be researched at state-of-the-art laboratories in Surrey. The brand new National Biosecurity Centre in Weybridge will aim to prevent future pandemics by keeping various incurable and fatal viruses in its facilities. It will be handed the highest classification of lab biosecurity, allowing researchers to study the deadliest diseases, known as biosafety level four pathogens, which include Ebola. This upgrade in rating gives it the same classification as the UK Healthy Security Agency base at Porton Down. But operations in Weybridge will take on a much wider scope, with the facility set to analyse a range of infected farm animals, not just rodents. The facility will also help prepare for the possibility of a terror attack involving biological weapons. Staff at the site will do their research in special self-contained suits with their own air supply, air locks, negative air pressure and disinfection showers, allowing them to safely handle the dangerous viruses. They will also analyse currently unknown diseases including Disease X, a hypothetical pathogen that will lead to the next pandemic. On Monday, the Department for Environment, Food & Rural Affairs announced it would fund the labs with £1billion of taxpayer money, part of a larger £2.8bn revamp of the Government's premier animal disease centre. It comes after warnings from the National Audit Office that the Government was not properly prepared for a major outbreak of animal disease. Such diseases include bird flu, bluetongue and African swine fever and can pose serious threats to England's farming sector, food security, and wildlife, and are a major and increasing risk to public health. About 60 per cent of all known human infectious diseases can be transmitted from animals to people, and three quarters of emerging infectious diseases originate in animals, officials warned. The 'record' investment will complete the redevelopment of the crumbling animal science facilities at Weybridge, which the National Audit Office (NAO) recently warned was at 'very high' risk of site failure. Environment Secretary Steve Reed said: 'The first role of any Government is national security. 'That is why we are making a record investment into the nation's biosecurity capabilities and, in turn, our national security, after years of chronic underfunding. 'Farmers and food producers will now be better protected from diseases, our food security strengthened, and public health better safeguarded against future pandemics.' Jenny Stewart, senior science director at the Animal and Plant Health Agency, which runs the labs, said the funding was a 'vital milestone' in the delivery of the new facilities. 'Our scientists and specialists at Weybridge are at the heart of the UK's disease surveillance and response capability and provide a global centre of expertise,' she added. 'Investment on this scale will enable them to continue their critical work in modern, fit-for-purpose facilities, supported by the very latest technologies.' The Government said work was already under way at the Weybridge site, with the first interim labs to support science ready in 2027 and 2028, and the national biosecurity centre due to be operational in 2033-34.
